- Title
- Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
- Creators
- John Burn (Author)Anne-Marie Gerdes (Author)Finlay Macrae (Author)Jukka-Pekka Mecklin (Author)Gabriela Moeslein (Author)Sylviane Olschwang (Author)Diane Eccles (Author)D. G. Evans (Author)Eamonn R. Maher (Author)Lucio Bertario (Author)Marie-Luise Bisgaard (Author)Malcolm G. Dunlop (Author)Judy W. Ho (Author)Shirley V. Hodgson (Author)Annika Lindblom (Author)Jan Lubinski (Author)Patrick J. Morrison (Author)Victoria Murday (Author)Raj Ramesar (Author)Lucy Side (Author)Rodney J. Scott (Author)Huw J. Thomas (Author) - Creighton UniversityHans F. Vasen (Author)Gail Barker (Author)Gillian Crawford (Author)Faye Elliott (Author)Mohammad Movahedi (Author)Kirsi Pylvanainen (Author)Juul T. Wijnen (Author)Riccardo Fodde (Author)Henry T. Lynch (Author) - Creighton UniversityJohn C. Mathers (Author)D. T. Bishop (Author)
- Additional links
- http://dx.doi.org/10.1016/S0140-6736(11)61049-0
- Publication Details
- Lancet, Vol.378(9809), pp.2081-2087
- Number of pages
- 2081-2087
- Identifiers
- 991005931060602656
- Academic Unit
- Prev. Medicine & Public Health; School of Medicine
- Resource Type
- Journal article
Journal article
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
Lancet, Vol.378(9809), pp.2081-2087
2011
Metrics
4 Record Views